Table 1 summarize the effects of Nrf2 inducers in the COPD model. Despite the promising in vivo and in vitro results, no Nrf2 inducer has thus far shown benefit in COPD patients. The gene discussed is GABPA; the disease is chronic obstructive pulmonary disease.